Coloplast CEO struggling to find good acquisition candidate
Medtech company Coloplast is still searching high and low for a suitable acquisition to its skin and wound care business. The likelihood of finding something good is not that high at the moment, says the CEO.
BY BENJAMIN WERNER CHRISTENSEN, TRANSLATED BY CATHERINE BRETT
Coloplast's skin and wound care business is lucrative, but is still too small to live up to its potential - though CEO Kristian Villumsen has plans to change that.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Coloplast sets climate goals for executive bonus program
For subscribers
